Portolan Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.84M Sell
30,763
-14,305
-32% -$4.11M 0.55% 58
2025
Q1
$13.9M Buy
45,068
+30,819
+216% +$9.5M 1.06% 34
2024
Q4
$5.03M Sell
14,249
-16,257
-53% -$5.74M 0.34% 91
2024
Q3
$10.9M Sell
30,506
-24,339
-44% -$8.72M 0.79% 43
2024
Q2
$17.5M Sell
54,845
-56,077
-51% -$17.9M 1.44% 17
2024
Q1
$25.5M Buy
110,922
+19,114
+21% +$4.39M 1.94% 12
2023
Q4
$20.2M Buy
91,808
+10,760
+13% +$2.37M 1.77% 11
2023
Q3
$18.3M Buy
81,048
+47,582
+142% +$10.7M 1.71% 12
2023
Q2
$7.39M Sell
33,466
-44,282
-57% -$9.78M 0.65% 43
2023
Q1
$17.4M Sell
77,748
-1,069
-1% -$239K 1.66% 13
2022
Q4
$21.9M Sell
78,817
-2,473
-3% -$688K 2.17% 6
2022
Q3
$17M Sell
81,290
-3,554
-4% -$744K 1.8% 13
2022
Q2
$20M Buy
+84,844
New +$20M 2.01% 9
2020
Q3
Sell
-75,039
Closed -$9.08M 155
2020
Q2
$9.08M Sell
75,039
-39,738
-35% -$4.81M 1.04% 33
2020
Q1
$10.9M Buy
+114,777
New +$10.9M 1.63% 17
2018
Q1
Sell
-34,227
Closed -$5.06M 113
2017
Q4
$5.06M Sell
34,227
-11,962
-26% -$1.77M 0.55% 67
2017
Q3
$5.41M Buy
+46,189
New +$5.41M 0.65% 61
2017
Q2
Sell
-33,469
Closed -$4.53M 136
2017
Q1
$4.53M Sell
33,469
-47,447
-59% -$6.42M 0.59% 66
2016
Q4
$11.6M Buy
80,916
+34,635
+75% +$4.97M 1.56% 15
2016
Q3
$5.47M Sell
46,281
-70,320
-60% -$8.3M 0.75% 54
2016
Q2
$12.4M Buy
116,601
+12,180
+12% +$1.29M 1.78% 13
2016
Q1
$11.6M Buy
104,421
+75,466
+261% +$8.41M 1.56% 16
2015
Q4
$4.54M Buy
+28,955
New +$4.54M 0.57% 70